These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20712391)

  • 1. Clinical and economic outcomes after introduction of drug-eluting stents.
    Rihal CS; Ryan JL; Singh M; Lennon RJ; Bresnahan JF; Liesinger JT; Gersh BJ; Ting HH; Holmes DR; Long KH
    Am J Manag Care; 2010 Aug; 16(8):580-7. PubMed ID: 20712391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
    Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes.
    Hayes KR; Applegate RJ; Sacrinty MT; Kutcher MA; Gandhi SK; Santos RM; Little WC
    J Invasive Cardiol; 2010 Jun; 22(6):266-70. PubMed ID: 20516505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of diabetics receiving bare-metal stents versus drug-eluting stents.
    Ramanath VS; Brown JR; Malenka DJ; DeVries JT; Sidhu MS; Robb JF; Jayne JE; Hettleman BD; Friedman BJ; Niles NW; Kaplan AV; Thompson CA;
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):473-81. PubMed ID: 20882647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort.
    Bental T; Assali A; Vaknin-Assa H; Lev EI; Brosh D; Fuchs S; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2010 Sep; 76(3):374-80. PubMed ID: 20839351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of drug-eluting stent use in patients with ST elevation myocardial infarction.
    Gurvitch R; Lefkovits J; Warren RJ; Duffy SJ; Clark DJ; Eccleston D; Yan BP; Reid C; Brennan A; Andrianopoulos N; Ajani AE
    Int J Cardiol; 2010 Sep; 143(3):283-8. PubMed ID: 19344962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
    Kim YH; Park DW; Lee SW; Yun SC; Lee CW; Hong MK; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ;
    Circulation; 2009 Aug; 120(5):400-7. PubMed ID: 19620506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis.
    Singh IM; Filby SJ; Sakr FE; Gorodeski EZ; Lincoff AM; Ellis SG; Shishehbor MH
    Catheter Cardiovasc Interv; 2010 Feb; 75(3):338-42. PubMed ID: 19937786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions.
    Jeger RV; Schneiter S; Kaiser C; Bonetti PO; Brunner-La Rocca H; Handke M; Osswald S; Buser PT; Pfisterer ME;
    Cardiology; 2009; 112(1):49-55. PubMed ID: 18580059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
    Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive plaque modification with rotational atherectomy and/or cutting balloon before drug-eluting stent implantation for the treatment of calcified coronary lesions.
    Vaquerizo B; Serra A; Miranda F; Triano JL; Sierra G; Delgado G; Puentes A; Mojal S; Brugera J
    J Interv Cardiol; 2010 Jun; 23(3):240-8. PubMed ID: 20636844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of drug-eluting and bare-metal stents for patients with off- and on-label indications.
    Ko DT; Chiu M; Guo H; Austin PC; Goeree R; Cohen E; Labinaz M; Tu JV
    J Am Coll Cardiol; 2009 May; 53(19):1773-82. PubMed ID: 19422984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes.
    Applegate RJ; Sacrinty MT; Kutcher MA; Santos RM; Gandhi SK; Little WC
    Circ Cardiovasc Interv; 2009 Feb; 2(1):35-42. PubMed ID: 20031691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.
    Yan BP; Ajani AE; New G; Duffy SJ; Farouque O; Shaw J; Sebastian M; Lew R; Brennan A; Andrianopoulos N; Reid C; Clark DJ;
    Int J Cardiol; 2008 Nov; 130(3):374-9. PubMed ID: 18706719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical outcomes after drug eluting stent implantation in women with de novo coronary lesions. Results from the REAL (REgistro Regionale AngiopLastiche Emilia-Romagna) multicenter registry.
    Ortolani P; Solinas E; Guastaroba P; Casella G; Manari A; Piovaccari G; Balducelli M; Tondi S; Percoco G; Tarantino F; Passerini F; Rossi R; Vignali L; De Palma R; Grilli R; Marzocchi A
    Int J Cardiol; 2011 May; 149(1):55-62. PubMed ID: 20060183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes.
    Tamburino C; Di Salvo ME; Capodanno D; Palmerini T; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Piovaccari G; Bartorelli A; Briguori C; Ardissino D; Di Pede F; Ramondo A; Inglese L; Petronio AS; Bolognese L; Benassi A; Palmieri C; Filippone V; De Servi S
    Am J Cardiol; 2009 Jan; 103(2):187-93. PubMed ID: 19121434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.